CervoMed Inc.CRVONASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank46
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P46
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-1.71%
Q3 20250.76%
Q2 2025-67.29%
Q1 202551.63%
Q4 2024-65.84%
Q3 2024-120.50%
Q2 2024-54.64%
Q1 202443.92%
Q4 2023-193.92%
Q3 2023237.77%
Q2 2023-32.38%
Q1 202357.33%
Q4 2022-150.66%
Q3 2022271.11%
Q2 202215.28%
Q1 2022-56.33%
Q4 2021-1.78%
Q3 202110.67%
Q2 202135.72%
Q1 2021-52.49%
Q4 20203.29%
Q3 2020-11.65%
Q2 202010.29%
Q1 2020-43.74%
Q4 2019-13.25%
Q3 201917.52%
Q2 20191.78%
Q1 201912.22%
Q4 2018-57.98%
Q3 201824.56%
Q2 201822.78%
Q1 2018-43.54%
Q4 201746.24%
Q3 2017-52.04%
Q2 201718.08%
Q1 2017-142.00%
Q4 201624.16%
Q3 201634.79%
Q2 201638.27%
Q1 2016-79.92%